Lamisil Poses Serious Health Risks: Report
The Australian Adverse Drug Reactions Advisory Committee said earlier this month that it had received 722 reports of harmful side effects from terbinafine, an oral version of the cream used to treat skin and nail fungal infections, sold under the brand name Lamisil. Three of those patients died from liver failure.
“ADRAC reminds prescribers that oral terbinafine...
To view the full article, register now.